Capital Health and Temple University Hospital have entered into an affiliation for liver transplant and advanced surgical services. Under the terms of the affiliation, Capital Health patients who are approved candidates will receive liver transplants at Temple, but will receive pre- and post-transplant care and related diagnostic tests close to home at Capital Health Medical Center – Hopewell under the direction of both Capital Health and Temple physicians.
Capital Health offers bloodless liver surgery and liver auto-transplant surgery performed by Dr. Cataldo Doria, an internationally-renowned hepato-pancreato-biliary surgeon who helped develop these innovative techniques. As part of this new partnership, Temple patients who are candidates for these advanced surgical procedures will be referred to Capital Health.
Temple University Hospital’s team has decades of experience in caring for patients with chronic liver diseases, including hepatitis, alcoholic liver disease and liver cancer as well as those suffering from drug toxicity or a rare metabolic disease. Temple’s highly skilled, multidisciplinary team is led by Dr. Antonio Di Carlo, Associate Professor of Surgery at the Lewis Katz School of Medicine at Temple University (LKSOM) and Chief of Abdominal Organ Transplant Surgery at Temple University Hospital; and Dr. Lee F. Peng, Chief of Hepatology and Associate Professor of Medicine at LKSOM, and Medical Director of Liver Transplantation at Temple University Hospital.
As part of the new collaboration, Temple patients with pancreatic cancer who are appropriate candidates will also have access to complex open and robotic-assisted Whipple procedures performed by Dr. Doria at Capital Health.
For more information, visit capitalhealth.org.